Browsing Category
Pharma Industry News
4765 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Roche, Alnylam’s Zilebesiran meets primary endpoint in KARDIA-1 trial
Breaking news in the world of hypertension treatment, Roche and Alnylam Pharmaceuticals have announced the success of their…
Biocept and Plus Therapeutics sign licensing deal for CNSide technology
Biocept, Inc. and Plus Therapeutics, Inc. have entered a non-exclusive licensing agreement expanding their existing laboratory services. Under…
HumanFirst unveils precision measures platform for drug development
HumanFirst, a leader in cloud-based software and artificial intelligence (AI) powered insights for drug development, has announced a…
Verily, Kyverna Therapeutics forge collaboration for autoimmune research
Verily, an Alphabet precision health technology company, and Kyverna Therapeutics, a clinical-stage cell therapy company, have announced a…
Ind-Swift Labs to sell API and CRAMS business to Synthimed for Rs 1,650cr
In a groundbreaking move that has left the pharmaceutical sector buzzing, the Board of Directors of Ind-Swift Laboratories…
Lupin, Mark Cuban’s Cost Plus Drugs and COPD Foundation boost COPD treatment access
In a significant healthcare development, global pharmaceutical giant Lupin Limited (Lupin) has entered into a groundbreaking collaboration with…
Caplin Steriles gets FDA EIR approval for Chennai unit: A boost for injectables
Caplin Steriles Ltd, a subsidiary of Caplin Point Laboratories Ltd, has received the Establishment Inspection Report (EIR) from…
Cipla to acquire Actor Pharma to dominate South African OTC market
In a strategic move that amplifies its commitment to the Over-The-Counter (OTC) business, Cipla South Africa, a 100%…
BITT secures NIH funding for pioneering Sjögren’s syndrome treatment
Boston Immune Technologies and Therapeutics, Inc. (BITT), a leading clinical-stage biotechnology firm specializing in tumor necrosis factor superfamily…
Genentech’s Alecensa shows promise in Phase III ALINA study for early-stage ALK-positive NSCLC
Genentech, a Roche Group member, has announced positive results from its Phase III ALINA study evaluating Alecensa (alectinib),…